CRELD1 is an evolutionarily-conserved maturational enhancer of ionotropic acetylcholine receptors

  1. Manuela D'Alessandro
  2. Magali Richard
  3. Christian Stigloher
  4. Vincent Gache
  5. Thomas Boulin
  6. Janet E Richmond
  7. JeanLouis Bessereau  Is a corresponding author
  1. University of Lyon - INSERM - CNRS, France
  2. University of Illinois at Chicago, United States

Abstract

The assembly of neurotransmitter receptors in the endoplasmic reticulum limits the number of receptors delivered to the plasma membrane, ultimately controlling neurotransmitter sensitivity and synaptic transfer function. In a forward genetic screen conducted in the nematode C. elegans, we identified crld-1 as a gene required for the synaptic expression of ionotropic acetylcholine receptors (AChR). We demonstrated that the CRLD-1A isoform is a membrane-associated ER-resident protein disulfide isomerase (PDI). It physically interacts with AChRs and promotes the assembly of AChR subunits in the ER. Mutations of Creld1, the human ortholog of crld-1a, are responsible for developmental cardiac defects. We showed that Creld1 knockdown in mouse muscle cells decreased surface expression of AChRs and that expression of mouse Creld1 in C. elegans rescued crld-1a mutant phenotypes. Altogether these results identify a novel and evolutionarily-conserved maturational enhancer of AChR biogenesis, which controls the abundance of functional receptors at the cell surface.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Manuela D'Alessandro

    Institut NeuroMyoGene, University of Lyon - INSERM - CNRS, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Magali Richard

    Institut NeuroMyoGene, University of Lyon - INSERM - CNRS, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Christian Stigloher

    Institut NeuroMyoGene, University of Lyon - INSERM - CNRS, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6941-2669
  4. Vincent Gache

    Institut NeuroMyoGene, University of Lyon - INSERM - CNRS, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Thomas Boulin

    Institut NeuroMyoGene, University of Lyon - INSERM - CNRS, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Janet E Richmond

    Department of Biological Sciences, University of Illinois at Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. JeanLouis Bessereau

    Institut NeuroMyoGene, University of Lyon - INSERM - CNRS, Lyon, France
    For correspondence
    jean-louis.bessereau@univ-lyon1.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3088-7621

Funding

Association Française contre les Myopathies (Post-doctoral Fellowship 16451)

  • Manuela D'Alessandro

European Molecular Biology Organization (Long term Post-doctoral fellowship)

  • Christian Stigloher

Institut National de la Santé et de la Recherche Médicale (Junior Grant)

  • Thomas Boulin

Association Française contre les Myopathies (Myoneuralp)

  • JeanLouis Bessereau

Deutscher Akademischer Austauschdienst (Postdoctoral Program of the German Academic Exchange Service)

  • Christian Stigloher

Fédération pour la Recherche sur le Cerveau (Operation Espoir en tête 2013)

  • JeanLouis Bessereau

Fondation ARC pour la Recherche sur le Cancer (4th year PhD program 2011)

  • Magali Richard

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Oliver Hobert, Howard Hughes Medical Institute, Columbia University, United States

Version history

  1. Received: July 12, 2018
  2. Accepted: November 5, 2018
  3. Accepted Manuscript published: November 8, 2018 (version 1)
  4. Version of Record published: November 20, 2018 (version 2)

Copyright

© 2018, D'Alessandro et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,631
    views
  • 236
    downloads
  • 16
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Manuela D'Alessandro
  2. Magali Richard
  3. Christian Stigloher
  4. Vincent Gache
  5. Thomas Boulin
  6. Janet E Richmond
  7. JeanLouis Bessereau
(2018)
CRELD1 is an evolutionarily-conserved maturational enhancer of ionotropic acetylcholine receptors
eLife 7:e39649.
https://doi.org/10.7554/eLife.39649

Share this article

https://doi.org/10.7554/eLife.39649

Further reading

    1. Cell Biology
    Ruichen Yang, Hongshang Chu ... Baojie Li
    Research Article

    Elastic cartilage constitutes a major component of the external ear, which functions to guide sound to the middle and inner ears. Defects in auricle development cause congenital microtia, which affects hearing and appearance in patients. Mutations in several genes have been implicated in microtia development, yet, the pathogenesis of this disorder remains incompletely understood. Here, we show that Prrx1 genetically marks auricular chondrocytes in adult mice. Interestingly, BMP-Smad1/5/9 signaling in chondrocytes is increasingly activated from the proximal to distal segments of the ear, which is associated with a decrease in chondrocyte regenerative activity. Ablation of Bmpr1a in auricular chondrocytes led to chondrocyte atrophy and microtia development at the distal part. Transcriptome analysis revealed that Bmpr1a deficiency caused a switch from the chondrogenic program to the osteogenic program, accompanied by enhanced protein kinase A activation, likely through increased expression of Adcy5/8. Inhibition of PKA blocked chondrocyte-to-osteoblast transformation and microtia development. Moreover, analysis of single-cell RNA-seq of human microtia samples uncovered enriched gene expression in the PKA pathway and chondrocyte-to-osteoblast transformation process. These findings suggest that auricle cartilage is actively maintained by BMP signaling, which maintains chondrocyte identity by suppressing osteogenic differentiation.

    1. Cancer Biology
    2. Cell Biology
    Timothy J Walker, Eduardo Reyes-Alvarez ... Lois M Mulligan
    Research Article

    Internalization from the cell membrane and endosomal trafficking of receptor tyrosine kinases (RTKs) are important regulators of signaling in normal cells that can frequently be disrupted in cancer. The adrenal tumor pheochromocytoma (PCC) can be caused by activating mutations of the rearranged during transfection (RET) receptor tyrosine kinase, or inactivation of TMEM127, a transmembrane tumor suppressor implicated in trafficking of endosomal cargos. However, the role of aberrant receptor trafficking in PCC is not well understood. Here, we show that loss of TMEM127 causes wildtype RET protein accumulation on the cell surface, where increased receptor density facilitates constitutive ligand-independent activity and downstream signaling, driving cell proliferation. Loss of TMEM127 altered normal cell membrane organization and recruitment and stabilization of membrane protein complexes, impaired assembly, and maturation of clathrin-coated pits, and reduced internalization and degradation of cell surface RET. In addition to RTKs, TMEM127 depletion also promoted surface accumulation of several other transmembrane proteins, suggesting it may cause global defects in surface protein activity and function. Together, our data identify TMEM127 as an important determinant of membrane organization including membrane protein diffusability and protein complex assembly and provide a novel paradigm for oncogenesis in PCC where altered membrane dynamics promotes cell surface accumulation and constitutive activity of growth factor receptors to drive aberrant signaling and promote transformation.